Real life experiences in HCV management in 2018-Reference-Cited by-同舟云学术

Real life experiences in HCV management in 2018

Published:2019-01-15 Issue:2 Volume:17 Page:117-128
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Viganò Mauro¹,Andreoni Massimo²,Perno Carlo Federico³,Craxì Antonio⁴,Aghemo Alessio⁵,Alberti Alfredo⁶,Andreone Pietro⁷,Babudieri Sergio⁸,Bonora Stefano⁹,Brunetto Maurizia Rossana¹⁰^ORCID,Bruno Raffaele¹¹,Bruno Savino¹²,Calvaruso Vincenza⁴,Caporaso Nicola¹³,Cartabellotta Fabio¹⁴,Ceccherini-Silberstein Francesca¹⁵,Cento Valeria³,Ciancio Alessia¹⁶,Colombatto Piero¹⁰^ORCID,Coppola Nicola¹⁷,Di Marco Vito⁴,Di Perri Giovanni⁹,Fagiuoli Stefano¹⁸,Gaeta Giovanni Battista¹⁹,Gasbarrini Antonio²⁰^ORCID,Lampertico Pietro²¹,Pellicelli Adriano²²,Prestileo Tullio²³,Puoti Massimo²⁴,Raimondo Giovanni²⁵,Rizzardini Giuliano²⁶,Taliani Gloria²⁷,Zignego Anna Linda²⁸^ORCID

Affiliation:

1. Hepatology Unit, Ospedale San Giuseppe, University of Milan, Milan, Italy

2. Department Medicine of Systems, University Tor Vergata, Rome, Italy

3. Department of Laboratory Medicine, Niguarda Hospital, University of Milan, Milan, Italy

4. Department of Gastroenterology, DiBiMIS, University of Palermo, Palermo, Italy

5. UO Medicina Interna ed Epatologia, Humanitas University and Research Hospital, Milano, Italy

6. Department of Molecular Medicine, University of Padua, Padua, Italy

7. Centro per lo Studio e Ricerche delle Epatiti, Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy

8. Infectious Diseases Department, AOU Sassari, University of Sassari, Sassari, Italy

9. Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy

10. Dipartimento di Medicina Clinica e Sperimentale Università di Pisa, UO Epatologia Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy

11. Division of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy

12. Department of Internal Medicine, Humanitas University Medicine, Rozzano, Italy

13. Department of Clinical Medicine and Surgery, Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy

14. Department of Internal Medicine, Buccheri La Ferla Hospital Fatebenefratelli, Palermo, Italy

15. Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy

16. Dipartimento di Scienze Mediche, Università di Torino, Torino, Italy

17. Infectious Diseases Unit, AORN Caserta, University of Campania, Caserta, Italy

18. USC Gastroenterologia Epatologia e Trapiantologia, Dipartimento di Medicina Specialistica e dei Trapianti, ASST Papa Giovanni XXIII, Bergamo, Italy

19. Malattie Infettive, Università della Campania “Luigi Vanvitelli”, Napoli, Italy

20. Fondazione Policlinico Gemelli IRCCS, Universita’ Cattolica del Sacro Cuore, Roma, Italy

21. Gastroenterology and Hepatology Division, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Università di Milano, Milano, Italy

22. UOC Malattie del Fegato Dipartimento Interaziendale Trapianti Azienda Ospedaliera San Camillo Forlanini, Rome, Italy

23. Infectious Diseases Unit and Centre for Migration and Health ARNAS, Civico-Benfratelli Hospital, Palermo, Italy

24. SC Malattie Infettive, Department of Infectious Diseases, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

25. Division of Clinical and Molecular Hepatology, Department of Internal Medicine, University Hospital of Messina, Messina, Italy

26. Infectious Diseases Department ASST Fatebenefratelli Sacco, School of Clinical Medicine, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa

27. Infectious Diseases Unit and School of Tropical Medicine, Sapienza of Rome University, Rome, Italy

28. Department of Experimental and Clinical Medicine and Department of Oncology, Interdepartmental Hepatology Center MASVE, Azienda Ospedaliero-Universitaria Careggi (AOUC), Florence, Italy

Funder

funded by an unrestricted grant from Gilead Sciences

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2019.1563755

Reference85 articles.

1. Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel

2. Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment

3. Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease

4. Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA);Therapeutics and Clinical Risk Management;2023-01

2. Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept “Compensated Advanced Chronic Liver Disease”;Journal of Clinical Medicine;2021-07-28

3. Drug–Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study;International Journal of Environmental Research and Public Health;2021-07-03

4. Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study;Digestive and Liver Disease;2021-05

5. Hepatitis C diagnosis and treatment in people who use drugs: mind the gap in the linkage to care;EUR REV MED PHARMACO;2021